source
- Novo sues Lilly, alleging ‘misleading’ advertising of obesity drugsThe lawsuit follows a cease-and-desist request and argues Lilly is using “deceptive” ads to claim its GLP-1 products are broadly superior to Novo’s medicines. Lilly countered that its campaign is “…BioPharma Dive · 9d ago↗ source
- Dimension restocks with $800M to capitalize on AI’s ‘rapid ascent’The young venture firm, which has bet heavily on tech and biotech’s convergence, has now invested in 35 companies and recently saw one of them acquired by AI giant Anthropic.BioPharma Dive · 9d ago↗ source
- Novartis climbs on upbeat drug sales as key readouts loomA return to quarterly sales growth boosted shares higher on Tuesday, though a handful of coming study results will have a bigger impact on the company’s long-term outlook.